All In Biotech

Free tool

FAERS Monitor: Valcyte

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022257 or its brand name (Valcyte, Valganciclovir Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

19,081

Serious

17,710

93% of reports

Hospitalization

9,377

Death reported

3,264

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use3,071
  • cytomegalovirus infection1,840
  • drug ineffective1,540
  • neutropenia1,189
  • pyrexia967
  • leukopenia960
  • diarrhoea952
  • acute kidney injury862
  • cytomegalovirus viraemia770
  • death762
  • pancytopenia717
  • drug resistance683
  • anaemia677
  • transplant rejection644
  • thrombocytopenia640

Reports by year received

View as table
YearReports
200483
2005143
2006102
2007115
2008144
2009159
2010175
2011409
2012518
2013413
2014513
2015555
2016608
20171,078
20181,375
20191,683
20201,823
20211,563
20221,563
20231,673
20241,891
20251,509
2026986

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,035,078 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
cytomegalovirus viraemiaSignal770230.5213.5145,352
cytomegalovirus infectionSignal1,840137.1130.9221,131
transplant rejectionSignal64496.288.955,750
drug resistanceSignal68330.127.918,687
leukopeniaSignal96021.520.218,475
pancytopeniaSignal71714.313.38,775
neutropeniaSignal1,1899.79.29,266
thrombocytopeniaSignal6406.35.92,872
acute kidney injurySignal8626.25.83,793
anaemiaSignal6773.93.61,480
off label useSignal3,0713.93.86,811
pyrexiaSignal9673.12.91,381
diarrhoea9521.61.5236
drug ineffective1,5401.31.2106
death7621.00.90

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.